- Home
- PMVP vs SWZ Comparison
PMVP vs SWZ Comparison
Compare PMVP & SWZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- SWZ
- Stock Information
- Founded
- PMVP 2013
- SWZ 1986
- Country
- PMVP United States
- SWZ United States
- Employees
- PMVP N/A
- SWZ N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- SWZ Finance Companies
- Sector
- PMVP Health Care
- SWZ Finance
- Exchange
- PMVP Nasdaq
- SWZ Nasdaq
- Market Cap
- PMVP 68.9M
- SWZ 76.6M
- IPO Year
- PMVP 2020
- SWZ N/A
- Fundamental
- Price
- PMVP $1.33
- SWZ $6.06
- Analyst Decision
- PMVP Strong Buy
- SWZ
- Analyst Count
- PMVP 1
- SWZ 0
- Target Price
- PMVP $5.00
- SWZ N/A
- AVG Volume (30 Days)
- PMVP 259.0K
- SWZ 14.2K
- Earning Date
- PMVP 11-12-2025
- SWZ 01-01-0001
- Dividend Yield
- PMVP N/A
- SWZ 6.59%
- EPS Growth
- PMVP N/A
- SWZ N/A
- EPS
- PMVP N/A
- SWZ N/A
- Revenue
- PMVP N/A
- SWZ N/A
- Revenue This Year
- PMVP N/A
- SWZ N/A
- Revenue Next Year
- PMVP N/A
- SWZ N/A
- P/E Ratio
- PMVP N/A
- SWZ N/A
- Revenue Growth
- PMVP N/A
- SWZ N/A
- 52 Week Low
- PMVP $0.81
- SWZ $7.12
- 52 Week High
- PMVP $1.84
- SWZ $8.57
- Technical
- Relative Strength Index (RSI)
- PMVP 47.49
- SWZ 54.71
- Support Level
- PMVP $1.30
- SWZ $5.90
- Resistance Level
- PMVP $1.44
- SWZ $6.07
- Average True Range (ATR)
- PMVP 0.08
- SWZ 0.05
- MACD
- PMVP -0.00
- SWZ 0.00
- Stochastic Oscillator
- PMVP 50.00
- SWZ 73.53
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.